SOPH Company Profile and Key Details

Short-term trend indicators are mixed aligned (SMA20 -5.35%, SMA50 -7.02%, SMA200 14.1%). The stock’s 14-day RSI is 38.62 (weak momentum), while the ATR of 0.27 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -19.82% below its high and over 77.13% above its low. Average 10-day trading volume of 66.77 thousand shares is below the 3-month average of 106.14 thousand, indicating normal recent market interest.

SOPHiA GENETICS S.A. has 67.58 million shares outstanding. The public float is 50.71 million shares, elevated short interest at 0.08% of float. This equals 40.89 thousand shares. The short ratio is 0.53 days. Institutional investors hold 51.99% of the float. Insiders own 8.38%. Camblong Jurgi holds 3.64 million shares, Muken Ross has 681.67 thousand shares and Xu Zhenyu has 630.89 thousand shares. Over the past six months, insider transactions show net selling. They sold 187.75 thousand shares across 60 transactions.

SOPHiA GENETICS S.A. generated EPS of -$1.12 over the past year. Five-year average earnings growth is -12.32%. Wall Street analysts project EPS growth of 8.2% annually over the next five years. The latest quarter delivered EPS of -$0.28. The next quarter is forecast at -$0.24. Next year's EPS is expected at $22.92. Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $8.00 to $7.00. The high target offers 59.36% upside. The low target suggests 39.44% downside. The mean target is $7.50. This offers 49.4% upside. SOPHiA GENETICS S.A. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended March 03, 2026, missed forecasts by 17.89%. The prior quarter beat by 130.77%. Over the last six quarters, Apple has recorded several small beats. These include 16.67% in November 05, 2024.

Dividend and splits history remains an important factor for investors monitoring long-term returns.

SOPHiA GENETICS S.A. (NASDAQ:SOPH) closed at $5.02 USD, losing -$0.05 (-0.99%) from the previous close of $5.07. The stock is currently mid-range between its 52-week high and low $2.59 and $5.70. With a market capitalization of about $359.78 million, SOPHiA GENETICS S.A. is classified as a small-cap and shows market-like volatility (beta ~1.01). Key stats such as the average daily volume over the past year has been around 104.28 thousand shares, volume is running light vs its 52-week average. Headquartered in Rolle, None, SOPHiA GENETICS S.A. operates in the Healthcare sector and the Medical - Healthcare Information Services industry. Led by CEO Jurgi Camblong, the company employs approximately 423 people and listed since July 23, 2021. SOPHiA GENETICS SA operates as a healthcare technology company.

SOPHiA GENETICS S.A. trades at a P/E ratio of -4.28, slightly below the S&P 500 average, with a price-to-sales ratio of 4.6 and a price-to-book ratio of 7.18 trading at moderately above to book value. The P/FCF stands at -8.75, also below market averages.

Our AI price prediction model suggests that SOPHiA GENETICS S.A. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 2.39%, with price expected at $5.14 by May 20, 2026, within a range of $4.94 to $5.35 3-Month Outlook: Projected rise of 18.53%, reaching $5.95 by August 04, 2026, with a range of $5.80 to $6.12. 1-Year Outlook: Projected gain of 414.14%, with price at $25.81 by May 06, 2027, within a range of $24.21 to $33.86.

SOPHiA GENETICS S.A. (NASDAQ:SOPH) shares are up 11.78% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows SOPHiA GENETICS S.A. trading at a premium to the broader market with a P/E of -4.28. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $8.92, suggesting 77.69% upside. Our AI forecast model points to short-term strength (2.39% over two weeks), a medium-term rise (18.53% over three months), and a longer-term gain (414.14% over one year), with expected trading ranges indicating moderate volatility.